× Industry Reports Services Press Release Contact us About us

Asia Pacific In Vitro Diagnostics (IVD) Market Forecast 2027 By Test Type (Clinical Chemistry, Immunoassay/Immunochemistry, Molecular Diagnostics, Hematology, Urinalysis), By Product (Reagents & Kits, Instruments), By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/Pharmacogenomics), By End-Use (Hospitals, Diagnostic Laboratories, Academic & Research Institutes), Research Report, Country Outlook (China, Japan, India, South Korea, Australia, Indonesia, Singapore, Malaysia, Taiwan, Thailand, Philippines), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
Published Date: January 2022 | Publisher: Graphical Research Report ID: GR1012 | Delivery : PDF  Request Free Sample

Report Content

Chapter 1   Methodology

1.1    Definition and forecast parameters

1.1.1    Definitions

1.1.2    Methodology and forecast parameters

1.2    Data sources

1.3    References & sources

1.3.1    Secondary

1.3.2    Primary

Chapter 2   Executive Summary

2.1    Asia Pacific in vitro diagnostics industry summary, 2016 – 2027

2.1.1    Business trends

2.1.2    Product type trends

2.1.3    Test type trends

2.1.4    Application trends

2.1.5    End-use trends

2.1.6    Country trends

Chapter 3   Industry Insights

3.1    Industry segmentation

3.2    Industry outlook, 2016 – 2027

3.3    Major factor analysis

3.3.1    Growth drivers

3.3.1.1    Rising incidence of growth disorders

3.3.1.2    Growing R&D activities in growth hormone industry

3.3.1.3    Rising awareness about the synthetic growth hormone therapy

3.3.2    Restraints & challenges

3.3.2.1    High cost of synthetic growth hormone treatment

3.3.2.2    Side effects associated with use of synthetic growth hormones

3.4    Growth potential analysis

3.4.1    By product type

3.4.2    By test type

3.4.3    By application

3.4.4    By end-use

3.5    COVID-19 impact analysis

3.6    Porter’s analysis

3.7    PEST analysis

3.8    Competitive review, 2020

Chapter 4   Asia Pacific In Vitro Diagnostics Market, By Product Type

4.1    Key trends in Asia Pacific in Vitro Diagnostics Market, by product type

4.2    Reagents & Kits

4.2.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

4.3    Instruments

4.3.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

Chapter 5   Asia Pacific In Vitro Diagnostics Market, By Test Type

5.1    Key trends in Asia Pacific in vitro diagnostics market, by application

5.2    Clinical chemistry

5.2.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

5.3    Immunoassay/Immunochemistry

5.3.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

5.4    Molecular diagnostics

5.4.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

5.5    Hematology

5.5.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

5.6    Urinalysis

5.6.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

5.7    Others

5.7.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

Chapter 6   Asia Pacific In Vitro Diagnostics Market, By Application

6.1    Key trends in Asia Pacific in vitro diagnostics market, by application

6.2    Oncology

6.2.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.3    Infectious diseases

6.3.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.4    Diabetes

6.4.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.5    Cardiology

6.5.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.6    Nephrology

6.6.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.7    Autoimmune Diseases

6.7.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.8    Drug Testing/Pharmacogenomics

6.8.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.9    Others

6.9.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

Chapter 7   Asia Pacific In Vitro Diagnostics Market, By End-use

7.1    Key trends in Asia Pacific in vitro diagnostics market, by distribution channel

7.2    Hospitals

7.2.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

7.3    Diagnostic laboratories

7.3.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

7.4    Academic & research institutes

7.4.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

7.5    Others

7.5.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

Chapter 8   Asia Pacific In Vitro Diagnostics Market, By Country

8.1    Key trends in Asia Pacific in Vitro diagnostics market, by country

8.1.1    China

8.1.1.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.1.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.1.3    Market estimates and forecast, by application, 2016 – 2027

8.1.1.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.2    Japan

8.1.2.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.2.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.2.3    Market estimates and forecast, by application, 2016 – 2027

8.1.2.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.3    India

8.1.3.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.3.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.3.3    Market estimates and forecast, by application, 2016 – 2027

8.1.3.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.4    South Korea

8.1.4.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.4.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.4.3    Market estimates and forecast, by application, 2016 – 2027

8.1.4.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.5    Australia

8.1.5.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.5.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.5.3    Market estimates and forecast, by application, 2016 – 2027

8.1.5.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.6    Indonesia

8.1.6.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.6.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.6.3    Market estimates and forecast, by application, 2016 – 2027

8.1.6.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.7    Singapore

8.1.7.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.7.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.7.3    Market estimates and forecast, by application, 2016 – 2027

8.1.7.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.8    Malaysia

8.1.8.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.8.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.8.3    Market estimates and forecast, by application, 2016 – 2027

8.1.8.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.9    Taiwan

8.1.9.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.9.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.9.3    Market estimates and forecast, by application, 2016 – 2027

8.1.9.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.10    Thailand

8.1.10.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.10.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.10.3    Market estimates and forecast, by application, 2016 – 2027

8.1.10.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.11    Philippines

8.1.11.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.11.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.11.3    Market estimates and forecast, by application, 2016 – 2027

8.1.11.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.12    Others

8.1.12.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.12.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.12.3    Market estimates and forecast, by application, 2016 – 2027

8.1.12.4    Market estimates and forecast, by end-use, 2016 – 2027

Chapter 9   Company Profiles

9.1    Strategy dashboard, 2020

9.2    F. Hoffmann-La Roche AG

9.2.1    Business Overview

9.2.2    Financial data

9.2.3    Product landscape

9.2.4    Strategic outlook

9.2.5    SWOT analysis

9.3    Abbott

9.3.1    Business overview

9.3.2    Financial data

9.3.3    Product landscape

9.3.4    SWOT analysis

9.4    Danaher

9.4.1    Business Overview

9.4.2    Financial data

9.4.3    Product Landscape

9.4.4    SWOT analysis

9.5    Siemens Healthineers

9.5.1    Business overview

9.5.2    Financial data

9.5.3    Product landscape

9.5.4    SWOT analysis

9.6    BioMerieux

9.6.1    Business overview

9.6.2    Financial data

9.6.3    Product landscape

9.6.4    Strategic outlook

9.6.5    SWOT analysis

9.7    DiaSorin

9.7.1    Business Overview

9.7.2    Financial data

9.7.3    Product landscape

9.7.4    SWOT analysis

9.8    Bio-Rad Laboratories

9.8.1    Business overview

9.8.2    Financial data

9.8.3    Product landscape

9.8.4    SWOT analysis

9.9    Sysmex Corporation

9.9.1    Business Overview

9.9.2    Financial data

9.9.3    Product Landscape

9.9.4    SWOT analysis

9.10    Thermo Fisher Scientific

9.10.1    Business Overview

9.10.2    Financial data

9.10.3    Product Landscape

9.10.4    Strategy outlook

9.10.5    SWOT analysis

9.11    Qiagen

9.11.1    Business Overview

9.11.2    Financial data

9.11.3    Product Landscape

9.11.4    SWOT analysis

9.12    Ortho Clinical Diagnostics

9.12.1    Business Overview

9.12.2    Financial data

9.12.3    Product Landscape

9.12.4    SWOT analysis

9.13    Becton, Dickinson and Company.

9.13.1    Business Overview

9.13.2    Financial data

9.13.3    Product Landscape

9.13.4    SWOT analysis
 


Premium Report

Have questions?
  • Inquire Before Buying
  • Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

     1-800-986-6917

     [email protected]